Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex

Brain, Behavior, and Immunity

Volumn 43, Issue , 2015, Pages 149-158

  Garcia Oscos, Francisco ^a,b   Peña, David ^a   Housini, Mohammad ^a   Cheng, Derek ^a   Lopez, Diego ^c   Borland, Michael S ^a   Salgado Delgado, Roberto ^d   Salgado, Humberto ^e   D'Mello, Santosh ^a,f   Kilgard, Michael P ^a   Rose John, Stefan ^g   Atzori, Marco ^a,d  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^d UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^f SOUTHERN METHODIST UNIVERSITY   (United States)

^g UNIVERSITY OF KIEL   (Germany)

Author keywords

Anti inflammatory reflex; GABA; Interleukin 6; Lipopolysaccharide; Vagal nerve stimulation

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N (3 QUINUCLIDINYL)FURO[2,3 C]PYRIDINE 5 CARBOXAMIDE; PROTEIN INHIBITOR; SGP 130FC; UNCLASSIFIED DRUG;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; GABAERGIC TRANSMISSION; IMMUNE RESPONSE; MOUSE; NERVE EXCITABILITY; NEUROPHARMACOLOGY; NONHUMAN; PATCH CLAMP TECHNIQUE; PREFRONTAL CORTEX; RAT; SYNAPTIC INHIBITION; VAGUS NERVE STIMULATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; NEURAL INHIBITION; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PHYSIOLOGICAL; SYNAPSES; VAGUS NERVE STIMULATION;

EID: 84919338749     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.07.020     Document Type: Article

References (74)

1. Andersson U., Tracey K.J. Neural reflexes in inflammation and immunity. J. Exp. Med. 2012, 209:1057-1068.
2. Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu. Rev. Immunol. 2012, 30:313-335.
3. Atzori M., Garcia-Oscos F., Mendez J.A. Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications. Future Med. Chem. 2012, 4:2177-2192.
4. Atzori M., Garcia-Oscos F., Mendez J.A. Role of interleukin 6 in the etiology of hyper-excitable neuropsychiatric conditions: experimental evidence and therapeutical implications. Future Med. Chem. 2012, 4:15.
5. Atzori M., Kanold P.O., Pineda J.C., Flores-Hernandez J., Paz R.D. Dopamine prevents muscarinic-induced decrease of glutamate release in the auditory cortex. Neuroscience 2005, 134:1153-1165.
6. Atzori M., Lei S., Evans D.I.P., Kanold P.O., Phillips-Tansey E., McIntyre O., McBain C.J. Differential synaptic processing separates stationary from transient inputs to the auditory cortex. Nat. Neurosci. 2001, 4:1230-1237.
7. Audet M.C., Jacobson-Pick S., Wann B.P., Anisman H. Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain Behav. Immun. 2011, 25:1197-1205.
8. Bajbouj M., Lisanby S.H., Lang U.E., Danker-Hopfe H., Heuser I., Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 2006, 59:395-400.
9. Banerjee A., Garcia-Oscos F., Roychowdhury S., Galindo L.C., Hall S., Kilgard M.P., Atzori M. Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. Int. J Neuropsychopharmacol. 2013, 16:1309-1318.
10. Bauer P.R., Kalitzin S., Zijlmans M., Sander J.W., Visser G.H. Cortical excitability as a potential clinical marker of epilepsy: a review of the clinical application of transcranial magnetic stimulation. Int. J. Neural Syst. 2014, 24:1430001.
11. Behrens M.M., Ali S.S., Dao D.N., Lucero J., Shekhtman G., Quick K.L., Dugan L.L. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007, 318:1645-1647.
12. Behrens M.M., Ali S.S., Dugan L.L. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J. Neurosci. 2008, 28:13957-13966.
13. Behrens M.M., Sejnowski T.J. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?. Neuropharmacology 2009, 57:193-200.
14. Berg B.M., Godbout J.P., Kelley K.W., Johnson R.W. Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav. Immun. 2004, 18:149-157.
15. Beurel E., Jope R.S. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J. Neuroinflamm. 2009, 6:9.
16. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
17. Braun O., Dewitz C., Moller-Hackbarth K., Scheller J., Schiffelholz T., Baier P.C., Rose-John S. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice. J. Interferon Cytokine Res. 2013, 33:254-260.
18. Burton M.D., Johnson R.W. Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning. Brain Behav. Immun. 2011.
19. Burton M.D., Rytych J.L., Freund G.G., Johnson R.W. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice. Brain Behav. Immun. 2013, 30:66-72.
20. Burton M.D., Sparkman N.L., Johnson R.W. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. J. Neuroinflamm. 2011, 19:8-54.
21. Caballero A., Diah K.C., Tseng K.Y. Region-specific upregulation of parvalbumin-, but not calretinin-positive cells in the ventral hippocampus during adolescence. Hippocampus 2013, 12:1331-1336.
22. Caballero A., Thomases D.R., Flores-Barrera E., Cass D.K., Tseng K.Y. Emergence of GABAergic-dependent regulation of input-specific plasticity in the adult rat prefrontal cortex during adolescence. Psychopharmacology 2013, 8:1789-1796.
23. Campbell I.L., Erta M., Lim S.L., Frausto R., May U., Rose-John S., Scheller J., Hidalgo J. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J. Neurosci. 2014, 34:2503-2513.
24. Cass D.K., Thomases D.R., Caballero A., Tseng K.Y. Developmental disruption of gamma-aminobutyric acid function in the medial prefrontal cortex by noncontingent cocaine exposure during early adolescence. Biol. Psychiatry 2013, 74:490-501.
25. Centonze D., Palmieri M.G., Boffa L., Pierantozzi M., Stanzione P., Brusa L., Marciani M., Siracusano A., Bernardi G., Caramia M. Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study. J. Psychiatry Neurosci. 2005, 30:127-132.
26. Chalaris A., Schmidt-Arras D., Yamamoto K., Rose-John S. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Dig. Dis. 2012, 30:492-499.
27. Chen Z., Yang J., Tobak A. Designing new treatments for depression and anxiety. IDrugs Invest. Drugs J. 2008, 11:189-197.
28. De Sarro G., Russo E., Ferreri G., Giuseppe B., Flocco M.A., Di Paola E.D., De Sarro A. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol. Biochem. Behav. 2004, 77:761-766.
29. Drugan R.C., Morrow A.L., Weizman R., Weizman A., Deutsch S.I., Crawley J.N., Paul S.M. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 1989, 487:45-51.
30. Dugan L.L., Ali S.S., Shekhtman G., Roberts A.J., Lucero J., Quick K.L., Behrens M.M. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS One 2009, 4:e5518.
31. Engineer N.D., Riley J.R., Seale J.D., Vrana W.A., Shetake J.A., Sudanagunta S.P., Borland M.S., Kilgard M. Reversing pathological neural activity using targeted plasticity. Nature 2010, 470:101-104.
32. Feleder C., Tseng K.Y., Calhoon G.G., O'Donnell P. Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol. Psychiatry 2010, 67:386-392.
33. Garcia-Oscos F., Salgado H., Hall S., Thomas F., Farmer G.E., Bermeo J., Galindo L.C., Ramirez R.D., D'Mello S., Rose-John S., Atzori M. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol. Psychiatry 2012, 71:574-582.
34. Geuze E., van Berckel B.N.M., Lammertsma A.A., Boellaard R., de Kloet C.S., Vermetten E., Westenberg H.G.M. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol. Psychiatry 2008, 13(74-83):73.
35. Girotti M., Donegan J.J., Morilak D.A. Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology 2011, 36:1164-1174.
36. Girotti M., Donegan J.J., Morilak D.A. Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 2013, 38:1158-1169.
37. Gonzalez-Burgos G., Barrionuevo G. Voltage-gated sodium channels shape subthreshold EPSPs in layer 5 pyramidal neurons from rat prefrontal cortex. J. Neurophysiol. 2001, 86:1671-1684.
38. Harrison E.L., Baune B.T. Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models. Transl. Psychiatry 2014, 4:e390.
39. Hashmi A.M., Butt Z., Umair M. Is depression an inflammatory condition? A review of available evidence. JPMA J. Pak. Med. Assoc. 2013, 63:899-906.
40. Hines R.M., Davies P.A., Moss S.J., Maguire J. Functional regulation of GABAA receptors in nervous system pathologies. Curr. Opin. Neurobiol. 2012, 22:552-558.
41. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62.
42. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 2001, 268:160-167.
43. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
44. Lachman H.M., Pedrosa E., Petruolo O.A., Cockerham M., Papolos A., Novak T., Papolos D.F., Stopkova P. Increase in GSK3beta gene copy number variation in bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:259-265.
45. Lee Y.J., Kim Y.K. The impact of glycogen synthase kinase 3beta gene on psychotic mania in bipolar disorder patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1303-1308.
46. Li S.Y., Chen X., Chen Y.L., Tan L., Zhao Y.L., Wang J.T., Xiang Q., Luo A.L. Role of GSK-3beta in isoflurane-induced neuroinflammation and cognitive dysfunction in aged rats. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2013, 33:530-535.
47. Marras C.E., Chiesa V., De Benedictis A., Franzini A., Rizzi M., Villani F., Ragona F., Tassi L., Vignoli A., Freri E., Specchio N., Broggi G., Casazza M., Canevini M.P. Vagus nerve stimulation in refractory epilepsy: new indications and outcome assessment. Epilepsy Behav. 2013, 28:374-378.
48. Mays J.W., Powell N.D., Hunzeker J.T., Hanke M.L., Bailey M.T., Sheridan J.F. Stress and the anti-influenza immune response: repeated social defeat augments clonal expansion of CD8(+)T cells during primary influenza a viral infection. J. Neuroimmunol. 2012, 243:34-42.
49. Merlot E., Moze E., Dantzer R., Neveu P.J. Cytokine production by spleen cells after social defeat in mice: activation of T cells and reduced inhibition by glucocorticoids. Stress 2004, 7:55-61.
50. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. J. Neurosci. 2011, 31:9075-9083.
51. Nelson T.E., Olde Engberink A., Hernandez R., Puro A., Huitron-Resendiz S., Hao C., De Graan P.N., Gruol D.L. Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6. Brain Behav. Immun. 2012, 26:959-971.
52. Nichols J.A., Nichols A.R., Smirnakis S.M., Engineer N.D., Kilgard M.P., Atzori M. Vagus Nerve Stimulation modulates cortical synchrony and excitability through the activation of muscarinic receptors. Neuroscience 2011, 189:207-214.
53. Penkowa M., Molinero A., Carrasco J., Hidalgo J. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 2001, 102:805-818.
54. Powell N.D., Bailey M.T., Mays J.W., Stiner-Jones L.M., Hanke M.L., Padgett D.A., Sheridan J.F. Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav. Immun. 2009, 23:225-231.
55. Rabe B., Chalaris A., May U., Waetzig G.H., Seegert D., Williams A.S., Jones S.A., Rose-John S., Scheller J. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 2008, 111:1021-1028.
56. Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 2012, 8:1237-1247.
57. Rossi S., De Capua A., Tavanti M., Calossi S., Polizzotto N.R., Mantovani A., Falzarano V., Bossini L., Passero S., Bartalini S., Ulivelli M. Dysfunctions of cortical excitability in drug-naive posttraumatic stress disorder patients. Biol. Psychiatry 2009, 66:54-61.
58. Salgado H., Garcia-Oscos F., Patel A., Martinolich L., Nichols J.A., Dinh L., Roychowdhury S., Tseng K.Y., Atzori M. Layer-specific noradrenergic modulation of inhibition in cortical layer II/III. Cereb. Cortex 2011, 21:212-221.
59. Sallmann S., Juttler E., Prinz S., Petersen N., Knopf U., Weiser T., Schwaninger M. Induction of interleukin-6 by depolarization of neurons. J. Neurosci. 2000, 20:8637-8642.
60. Samland H., Huitron-Resendiz S., Masliah E., Criado J., Henriksen S.J., Campbell I.L. Profound increase in sensitivity to glutamatergic - but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J. Neurosci. Res. 2003, 73:176-187.
61. Scheller J., Schuster B., Holscher C., Yoshimoto T., Rose-John S. No inhibition of IL-27 signaling by soluble gp130. Biochem. Biophys. Res. Commun. 2005, 326:724-728.
62. Sukoff Rizzo S.J., Neal S.J., Hughes Z.A., Beyna M., Rosenzweig-Lipson S., Moss S.J., Brandon N.J. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl. Psychiatry 2012, 2:e199.
63. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
64. Tseng K.Y., Lewis B.L., Hashimoto T., Sesack S.R., Kloc M., Lewis D.A., O'Donnell P. A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J. Neurosci. 2008, 28:12691-12699.
65. Turrigiano G.G. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 2008, 135:422-435.
66. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
67. Wang X., Lupardus P., Laporte S.L., Garcia K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 2009, 27:29-60.
68. Wani A., Trevino K., Marnell P., Husain M.M. Advances in brain stimulation for depression. Ann. Clin. Psychiatry 2013, 25:217-224.
69. Wei H., Alberts I., Li X. Brain IL-6 and autism. Neuroscience 2013, 252:320-325.
70. Wolf J., Rose-John S., Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 2014, 14:S1043.
71. Wondolowski J., Dickman D. Emerging links between homeostatic synaptic plasticity and neurological disease. Front. Cell. Neurosci. 2013, 7:223.
72. Yamamoto K., Rose-John S. Therapeutic blockade of interleukin-6 in chronic inflammatory disease. Clin. Pharmacol. Ther. 2012, 91:574-576.
73. Zhang H., Neuhofer P., Song L., Rabe B., Lesina M., Kurkowski M.U., Treiber M., Wartmann T., Regner S., Thorlacius H., Saur D., Weirich G., Yoshimura A., Halangk W., Mizgerd J.P., Schmid R.M., Rose-John S., Algul H. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J. Clin. Investig. 2013, 123:1019-1031.
74. Zhou X., Zhou J., Li X., Guo C., Fang T., Chen Z. GSK-3beta inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury. Biochem. Biophys. Res. Commun. 2011, 411:271-275.